Read + Share
Amedeo Smart
Independent Medical Education
Minnella A, McCusker KP, Amagata A, Trias B, et al. Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson's disease. PLoS One 2024;19:e0309893.PMID: 39292705
Email
LinkedIn
Privacy Policy